Health and Safety Authority – Consultation on the Development of HSA Strategy for 2025-2027

The Health and Safety Authority (HSA) is currently developing its next Strategy for the period 2025-2027. As part of this process, the HSA would welcome views on a range of issues as outlined below. Your inputs to the strategy would be greatly appreciated. Please complete this questionnaire by close of business Thursday 16th May. Thank you for your assistance.

Achievements of HSA

Question Title

* 1. What specific activities of the HSA do you believe have brought most value over the last 3 years?

Future External Environment

Question Title

* 2. What are the most important/significant external opportunities and threats likely to impact on the HSA during the period of the 2025-27 strategy? For example, these may be political, economic, social, technological, legal or environmental issues.

Suggestions for Next Strategy

Question Title

* 3. Do you have any specific suggestions for strategic priorities, goals and actions, and associated outcomes for the next Strategy Statement?

Other Issues

Question Title

* 4. Are there any other issues concerning the HSA Strategy Statement that you consider are relevant?

Background Details

Please provide your details below (optional):

Question Title

* 5. Name:

Question Title

* 6. Organisation:

Question Title

* 7. E-mail address:

Thank you very much for your assistance in completing this consultation input for the HSA. Please also feel free to send any additional submission on any relevant issue to Dr. Ronnie O’Toole, Partner, Indecon rotoole@indecon.ie.

Please note the HSA is subject to the provision of the Data Protection Act. Your details will not be used for any other purpose outside the process. Please note your individual responses to survey questions will be treated as strictly confidential and will be aggregated with those of other organisations. Please be aware that responses to this consultation may be subject to the provisions of the Freedom of Information Act 2014 (FOI). Confidential or commercially sensitive information should therefore be clearly identified in your submission. Respondents may be contacted again should there be a need for clarification with regards to an element of their submission. It should be noted that the publication of any potentially sensitive/confidential information, or attribution of information, will be discussed with respondents in the organisation in advance.